Depends on your geography and how many other hospital reps, s3's, etc are around you. Integrilin has another year on patent and it's falling like a rock. Now with MDCO partnering with Brilenta and ISAR 4, IIBIIIA days are over. There is no chance Vora will make it to keep a dedicated cardio salesforce.
Sugamadex should be approved but knowing Merck and the FDA, they will find a way to screw it up. You wont see any changes until FDA votes on suga but they will likely combine all of hospital at that point. With Suga, a 40% reduction in all of hospital would be about right. The hospital pill reps Port 1? are a joke but they are keeping them around for the mix up because they are all merck ppl who play the merck BS well.